China Pharmaceutical University, Shanghai Gobroad Cancer Hospital

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Phase 2 Study of WGI-0301 for Advanced HCC	Advanced Hepatocellular Carcinoma (HCC)	Recruiting	Phase 2	2026-09-11		NCT06309485
Phase 2 Study of WGI-0301 Plus Nivolumab in Patients With HCC and RCC	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, carcinoma, epithelial neoplasm, kidney cancer, kidney disorder, neoplasm, renal cell carcinoma, urinary system disorder	Not yet recruiting	Phase 2	2026-03-27		NCT07494435

Clinical trials